A carregar...
Publicação
fHER2, PR, ER, Ki-67 and cytokeratin 5/6 expression in benign feline mammary lesions
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.64 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Biomarkers are essential in the characterization of neoplastic lesions and aid not only in the classification of the nature of the lesions, but also in the understanding of their ontogeny, development and prognosis. In cats, while mammary carcinomas are increasingly being characterized, information on their benign lesions is still scarce. Indeed, a better characterization of benign lesions could have an important role in unravelling mammary oncogenesis, similar to that in human breast cancer. Thus, in this study, the expression of five markers was analyzed in 47 benign mammary lesions (hyperplasia, dysplasia and benign tumors) collected from 27 queens. Dysplastic and hyperplastic lesions were the most common (41/47, 81.7%). Most of the lesions were classified as ER positive (43/47, 91.5%), PR negative (30/47, 63.8%), fHER2 negative (29/47, 64.4%), CK 5/6 negative (36/47, 76.6%) and with a low Ki-67 index (37/47, 78.7%). Statistical analysis revealed a correlation between younger ages and ER positivity (p = 0.013) and between larger lesions and negative PR status (p = 0.038). These results reinforce the importance of evaluating the expression of the ER status, prevalent in benign lesions, as a putative precursor in cancer progression.
Descrição
Palavras-chave
premalignant lesions feline oncology estrogen receptor progesterone receptor HER2 Ki-67 cytokeratin 5/6
Contexto Educativo
Citação
Soares M, Correia AN, Batista MR, Correia J, Ferreira F. fHER2, PR, ER, Ki-67 and Cytokeratin 5/6 Expression in Benign Feline Mammary Lesions. Animals. 2022; 12(13):1599. https://doi.org/10.3390/ani12131599
Editora
MDPI